SEC filing signals material corporate event for CME Group, a derivatives market operator.
What changed
$CME 8-K: CME CEO Terrence Duffy to become Executive Chairman by March 2027, succeeded by President/CFO Lynne Fitzpatrick as CEO, with CFO search underway, ensuring leadership continuity.